Cancer
The role of surgery in locally advanced non-small cell lung cancer (NSCLC) is continuously evolving with the introduction of effective neoadjuvant systemic treatments. Beyond tumor reduction, treatment response may influence surgical decision-making by improving resectability...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about...
Mediastinal and intrathoracic germ cell tumors are rare in the pediatric population, and extragonadal yolk sac tumors presenting as giant thoracic masses are rarer still. These tumors pose a dual...
In this episode of The Atrium, host Alice Copperwheat speaks with Jessica Donington, Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago, Illinois,...
The role of surgery in locally advanced non-small cell lung cancer (NSCLC) is continuously evolving with the introduction of effective neoadjuvant systemic treatments. Beyond tumor reduction, treatment response may influence...
This study evaluated the surgical and oncological results of RATS thymectomy to demonstrate the approach as technically safe with acceptable outcomes. Of 669 patients, complete thymectomy was performed in 98...
Sublobar resection for early-stage non-small cell lung cancer has recently been compared with lobectomy in three randomized trials. This expert review summarizes and compares these three landmark trials and describes...
Of 57,531 patients who underwent lung cancer resection identified from The Society of Thoracic Surgeons General Thoracic Surgery Database, 758 (1.3 percent) were diagnosed with pulmonary embolism, which was most...
This study reviews 44 patients with stage IB (larger than 4 cm) to IIIA non-small cell lung cancer who were treated on sequential platform arms of the NEOSTAR trial. Twenty-two...
The authors of this paper explored early postoperative outcomes in all patients (n= 833) undergoing uniportal segmentectomy and lobectomy in their unit between 2017 and 2022. During this study period,...
This study aimed to evaluate the percentage of solitary fibrous pleural tumors presenting unfavorable clinical behavior to predict negative long-term outcomes. Although they are historically considered benign neoplasms, this retrospective...
This study surveyed 123 thoracic surgeons and posed several questions asking which surgical resection they would prefer if they themselves were diagnosed with several variations of lung cancer size and...
In this single-center series of 430 patients with stage I or II non-small cell lung cancer who underwent minimally invasive lobectomy (n = 200) or segmentectomy (n = 230), 162...



